Last Updated: 08/18/21
CISC 2021 Meeting: Harnessing Imaging Tools to Guide Immunotherapy Trials
Powerpoint Slides from the Meeting
| Title | Presenter |
|---|---|
| NCI Strategy and Current Landscape of Clinical Immunotherapy Trials | Elad Sharon, MD, MPH |
| Immunologic Chechpoint Blockabe: Learings from Melanoma | Jedd D. Wolchok, MD, PhD, FASCO |
| Session 2 - Opportunities and Challenges | Michael V. Knopp, MD, PhD |
| Harnessing Imaging Tools to Guide Immunotherapy Trials: FDG PET/CT | Richard L. Wahl, MD |
| iRANO (and mRANO) for Immunotherapy in Brain Tumors | Benjamin M. Ellingson, PhD |
| Imaging in the Immuno-oncology Era: Between Immune Response, Pseudoprogression and Hyperprogression: What do we know? | Lawrence Schwartz, MD |
| MR Imaging as Predictive and Prognostic Biomarker | Mukesh G. Harisinghani, MD |
| Update on Clinical Research Assessing CD8 ImmunoPET | Anna M. Wu, PhD |
| Update on Clinical Research Assessing PET Agent | David Leung, MD, PhD |